BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20808941)

  • 1. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.
    Alvarez S; Suela J; Valencia A; Fernández A; Wunderlich M; Agirre X; Prósper F; Martín-Subero JI; Maiques A; Acquadro F; Rodriguez Perales S; Calasanz MJ; Roman-Gómez J; Siebert R; Mulloy JC; Cervera J; Sanz MA; Esteller M; Cigudosa JC
    PLoS One; 2010 Aug; 5(8):e12197. PubMed ID: 20808941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.
    Figueroa ME; Lugthart S; Li Y; Erpelinck-Verschueren C; Deng X; Christos PJ; Schifano E; Booth J; van Putten W; Skrabanek L; Campagne F; Mazumdar M; Greally JM; Valk PJ; Löwenberg B; Delwel R; Melnick A
    Cancer Cell; 2010 Jan; 17(1):13-27. PubMed ID: 20060365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
    Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
    Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).
    Krali O; Palle J; Bäcklin CL; Abrahamsson J; Norén-Nyström U; Hasle H; Jahnukainen K; Jónsson ÓG; Hovland R; Lausen B; Larsson R; Palmqvist L; Staffas A; Zeller B; Nordlund J
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
    Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia.
    Griffiths EA; Gore SD; Hooker CM; Mohammad HP; McDevitt MA; Smith BD; Karp JE; Herman JG; Carraway HE
    Epigenetics; 2010 Oct; 5(7):590-600. PubMed ID: 20671427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.
    Hájková H; Fritz MH; Haškovec C; Schwarz J; Šálek C; Marková J; Krejčík Z; Dostálová Merkerová M; Kostečka A; Vostrý M; Fuchs O; Michalová K; Cetkovský P; Beneš V
    J Hematol Oncol; 2014 Sep; 7():66. PubMed ID: 25266220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescence in situ hybridization study of acute myeloid leukemia with cryptic chromosome rearrangements].
    Bai SX; Xue YQ; Chen SN; Pan JL; Wu YF; Shen J; Wang Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):690-3. PubMed ID: 22161107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
    Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
    Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of multiplex nested RT- PCR assay for screening the fusion genes in acute myeloid leukemia and its clinical significance].
    Xu Y; Gao L; Sun J; Ding Y; Xu Y; Lyu C; Liu W; Wang N; Wang L; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):29-34. PubMed ID: 24602728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.